Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,374 across all filing types
Latest filing 2021-05-20 AGM Information
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a notice of the Annual General Meeting (AGM) for CStone Pharmaceuticals, detailing the date, location, agenda items including re-election of directors, approval of financial statements, appointment of auditors, and resolutions related to share issuance and buy-back mandates. It is explicitly titled as a "NOTICE OF ANNUAL GENERAL MEETING" and contains no actual financial statements or detailed financial data, but rather the agenda and procedural information for the AGM. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the AGM. The document is lengthy (over 14,000 characters) but is clearly a meeting notice rather than a full annual report or financial report. Therefore, the correct classification is AGM Information (AGM-R).
2021-05-20 English
FORM OF PROXY FOR ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a 'Form of Proxy' for the Annual General Meeting (AGM) of CStone Pharmaceuticals. It is a voting instruction form allowing shareholders to appoint proxies to vote on their behalf at the AGM. It contains no financial data, no report content, and is not an announcement of voting results. It is directly related to the AGM meeting process and materials. Therefore, it fits the category of AGM Information (AGM-R), which includes presentations and materials shared during the AGM, including proxy forms.
2021-05-20 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE AND BUY BACK SHARES, RE-ELECTION OF RETIRING DIRECTORS, RE-APPOINTMENT OF AUDITORS AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a circular from the board of CStone Pharmaceuticals dated May 21, 2021, containing detailed proposals for the Annual General Meeting (AGM) scheduled for June 23, 2021. It includes information on general mandates to issue and buy back shares, re-election of retiring directors, re-appointment of auditors, and the notice of the AGM itself. The document contains a proxy form and detailed explanatory statements related to the AGM agenda items. The content is typical of materials sent to shareholders in advance of an AGM to inform them and solicit their votes. It is not the AGM minutes or results, nor is it a full annual report or financial statement. It is also not a simple announcement or notice but a comprehensive circular with detailed proposals and supporting information for the AGM. Therefore, the document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting.
2021-05-20 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2021-05-19 English
NOTIFICATION LETTER
AGM Information Classification · 100% confidence The document is a notification letter from Yanzhou Coal Mining Company Limited dated 18 May 2021. It informs shareholders about the availability of the 2020 Annual General Meeting (AGM) materials, including the notice, proxy form, and circular. It provides instructions on how shareholders can access these corporate communications online or request printed copies. The document explicitly states that it is a notice and proxy form for the 2020 AGM and class meeting, and it includes a change request form for shareholders to update their preferences for receiving future corporate communications. There is no actual financial data, detailed report, or analysis included in this document. It is essentially an announcement about the availability and distribution of AGM materials, not the AGM materials themselves. According to the classification rules, such a document is best classified as AGM Information (AGM-R) because it relates to the Annual General Meeting and provides related materials and notices to shareholders.
2021-05-18 English
Circular
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a detailed circular from Yanzhou Coal Mining Company Limited addressed to shareholders, containing multiple proposals to be voted on at the upcoming Annual General Meeting (AGM). It includes proposals such as renewal of liability insurance for directors, appointment of external auditors, authorization for financing activities, amendments to articles of association, and share issuance and repurchase mandates. The document references the AGM date and meeting logistics, and it is structured as a proxy solicitation and information statement to inform shareholders and solicit their votes on these matters. It is not a financial report, earnings release, or regulatory filing, but rather a comprehensive circular related to shareholder voting and meeting materials. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI). The document length (15,000 characters) and content confirm it is the full circular, not just an announcement or notice.
2021-05-18 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.